Your browser doesn't support javascript.
loading
Genetic diversity of HLA system in six populations from Mexico City Metropolitan Area, Mexico: Mexico City North, Mexico City South, Mexico City East, Mexico City West, Mexico City Center and rural Mexico City.
Barquera, Rodrigo; Martínez-Álvarez, Julio César; Hernández-Zaragoza, Diana Iraíz; Bravo-Acevedo, Alicia; Juárez-Nicolás, Francisco; Arriaga-Perea, Agustín Jericó; Vega-Martínez, María Del Rosario; Ortega-Yáñez, Andrea; Benítez-Arvizu, Gamaliel; Arrieta-Bolaños, Esteban; Clayton, Stephen; Juárez-Cortés, Eva Dolores; López-Gil, Concepción; García-Álvarez, Raquel; Arrazola-García, María Araceli; Martínez-Bezies, Virginia; Juárez-Barreto, Vicencio; Ramos-de la Cruz, Flor Del Rocío; Macías-Medrano, Rosa María; Méndez-Mani, Patricia; Escutia-González, Ariadna; Montiel-Hernández, Gustavo Daniel; Immel, Alexander; Pavón-Vargas, María de Los Ángeles; Salgado-Galicia, Norma; Novelo-Garza, Bárbara; Zúñiga, Joaquín; Yunis, Edmond J; Bekker-Méndez, Carolina; Granados, Julio.
Afiliação
  • Barquera R; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany; Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico. Electronic address: barquera@shh.mpg.de.
  • Martínez-Álvarez JC; HLA Laboratory, Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Hernández-Zaragoza DI; Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico; Immunogenetics Unit, Técnicas Genéticas Aplicadas a la Clínica (TGAC), Mexico City, Mexico.
  • Bravo-Acevedo A; Blood Bank, UMAE Hospital de Gineco Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Juárez-Nicolás F; Molecular Immunogenetics Laboratory, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
  • Arriaga-Perea AJ; Histocompatibility Laboratory, Central Blood Bank, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Vega-Martínez MDR; Molecular Biology and Histocompatibility Laboratory, Hospital Central Sur de Alta Especialidad, Petróleos Mexicanos (PEMEX), Mexico City, Mexico.
  • Ortega-Yáñez A; Department of Developmental Genetics and Molecular Physiology, Instituto de Biotecnología (IBT), Universidad Nacional Autónoma de México (UNAM), Cuernavaca, Morelos, Mexico.
  • Benítez-Arvizu G; Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Arrieta-Bolaños E; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.
  • Clayton S; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany.
  • Juárez-Cortés ED; Histocompatibility Laboratory, Central Blood Bank, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • López-Gil C; Histocompatibility Laboratory, Unidad Médica de Alta Especialidad (UMAE) # 6, Instituto Mexicano del Seguro Social (IMSS), Puebla, Puebla, Mexico.
  • García-Álvarez R; Pharmacology Laboratory, Research Unit, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
  • Arrazola-García MA; HLA Laboratory, Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Martínez-Bezies V; Qualth Medical System Laboratory, Mexico City, Mexico.
  • Juárez-Barreto V; Blood Bank, Hospital Infantil de México "Federico Gómez", Mexico City, Mexico.
  • Ramos-de la Cruz FDR; Histocompatibility Laboratory, Unidad Médica de Alta Especialidad (UMAE) # 6, Instituto Mexicano del Seguro Social (IMSS), Puebla, Puebla, Mexico.
  • Macías-Medrano RM; Histocompatibility Laboratory, Central Blood Bank, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Méndez-Mani P; Histocompatibility Laboratory, Unidad Médica de Alta Especialidad (UMAE) # 6, Instituto Mexicano del Seguro Social (IMSS), Puebla, Puebla, Mexico.
  • Escutia-González A; Molecular Immunogenetics Laboratory, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
  • Montiel-Hernández GD; Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico.
  • Immel A; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany; Institute of Clinical Molecular Biology (IKMB), Kiel University, University Hospital, Schleswig-Holstein, Germany.
  • Pavón-Vargas MLÁ; Histocompatibility Laboratory, Unidad Médica de Alta Especialidad (UMAE) # 6, Instituto Mexicano del Seguro Social (IMSS), Puebla, Puebla, Mexico.
  • Salgado-Galicia N; Molecular Biology and Histocompatibility Laboratory, Hospital Central Sur de Alta Especialidad, Petróleos Mexicanos (PEMEX), Mexico City, Mexico.
  • Novelo-Garza B; Medical Infrastructure Planning Committee, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Zúñiga J; Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
  • Yunis EJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bekker-Méndez C; Immunology and Infectology Research Unit, Infectology Hospital, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Granados J; Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" (INCMNSZ), Mexico City, Mexico. Electronic address: julgrate@yahoo.com.
Hum Immunol ; 81(9): 539-543, 2020 Sep.
Article em En | MEDLINE | ID: mdl-31353130
We studied HLA class I (HLA-A, -B) and class II (HLA-DRB1, -DQB1) alleles by PCR-SSP based typing in 1217 Mexicans from the Mexico City Metropolitan Area living in the northern (N = 751), southern (N = 52), eastern (N = 79), western (N = 33), and central (N = 152) Mexico City, and rural communities (N = 150), to obtain information regarding allelic and haplotypic frequencies. We found that the most frequent haplotypes include 11 Native American haplotypes. Admixture estimates revealed that the main genetic components are Native American (63.85 ±â€¯1.55% by ML; 57.19% of Native American haplotypes) and European (28.53 ±â€¯3.13% by ML; 28.40% of European haplotypes), and a less apparent African genetic component (7.61 ±â€¯1.96% by ML; 7.17% of African haplotypes).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Etnicidade / Genética Populacional / Antígenos HLA Limite: Humans País/Região como assunto: Mexico Idioma: En Revista: Hum Immunol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Etnicidade / Genética Populacional / Antígenos HLA Limite: Humans País/Região como assunto: Mexico Idioma: En Revista: Hum Immunol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos